Rhenman & Partners Asset Management’s Alignment Healthcare ALHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ALHC
Rhenman & Partners Asset Management's ALHC Position: Q2 2026 in Review
Rhenman & Partners Asset Management reduced its Alignment Healthcare (ALHC) stake by 5.4% in Q2 2026, selling an estimated $1.08M and leaving 997,083 shares worth $23.7M. The position accounts for 2.24% of the portfolio, ranked #7.
Rhenman & Partners Asset Management first reported a position in ALHC in Q3 2022 and has held it in 16 quarters since. The position peaked at $25.8M in Q3 2025. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.
- Rhenman & Partners Asset Management held 997,083 shares of Alignment Healthcare worth $23.7M as of Q2 2026.
- Rhenman & Partners Asset Management sold 56,367 Alignment Healthcare shares in Q2 2026, an estimated $1.08M.
- Alignment Healthcare made up 2.24% of Rhenman & Partners Asset Management's portfolio in Q2 2026, its #7 holding.
- Rhenman & Partners Asset Management first reported a position in Alignment Healthcare in Q3 2022 and has held it in 16 quarters since.
- Rhenman & Partners Asset Management's Alignment Healthcare position peaked at $25.8M in Q3 2025.
- 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.
Based on Rhenman & Partners Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.